Chapter 14 A contemporary history of ibogaine in the United States and Europe

Alkaloids: Chemistry and Biology

Volumn 56, Issue C, 2001, Pages 249-281

  Alper, Kenneth R ^a   Beal, Dana ^b   Kaplan, Charles D ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Cures not Wars New York   (United States)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; IBOGAINE; PSYCHEDELIC AGENT;

ADDICTION; ARTICLE; EUROPE; HISTORY; HUMAN; PATIENT ADVOCACY; UNITED STATES;

EUROPE; EXCITATORY AMINO ACID ANTAGONISTS; HALLUCINOGENS; HISTORY, 20TH CENTURY; HUMANS; IBOGAINE; PATIENT ADVOCACY; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 0035225905     PISSN: 10994831     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0099-9598(01)56018-6     Document Type: Review

References (81)

1. Wright C.R. Memorandum to Franck Vocci: Ibogaine (March 10, 1995)
2. Wachter R.M. N. Eng. J. Med. 326 (1992) 128
3. AIDS Coalition to Unleash Power (ACT UP). Capsule History (2000). http://www.actupny.org/documents/capsule-home.html
4. Alper K.R., Lotsof H.S., Frenken G.M.N., Luciano D.J., and Bastiaans J. Am. J. Addict. 8 (1999) 234
5. Mash D.C., Kovera C.A., Buck B.E., Norenberg M.D., Shapshak P., Hearn W.L., and Sanchez-Ramos J. Ann. N. Y. Acad. Sci. 844 (1998) 274
6. Mash D.C., and Kovera C.A. Ibogaine Is Effective in Blocking Opiate Withdrawal Symptoms: Role of the Metabolite Noribogaine. Sixty-Second Annual Scientific Meeting of the College of Problems on Drug Dependence. San Juan, Puerto Rico (June 2000)
7. Lotsof H.S. Multidiscip. Assoc. Psyched. Stud. Bull. 5 (1995) 16
8. Naranjo C. Clin. Toxicol. 2 (1969) 209
9. Naranjo C. The Healing Journey (1973), Pantheon Books, New York
10. Stolaroff M.J. The Secret Chief (1997), Multidisciplinary Association for Psychedelic Studies (MAPS), Charlotte, NC
11. Huxley A. The Doors of Perception (1954), Harper, New York
12. Leary T., Litwin G., and Metzner R. J. Nerv. Ment. Dis. 137 (1963) 561
13. McCrosky S. Overthrow 7 (1985) 11
14. DeRienzo P., and Beal D. The Ibogaine Story (1997), Autonomedia, New York
15. Schmidt W.K., Gorodetzky C.W., Teti N.L., Vocci F., Grossman S.A., and Mansbach R.S. Drug Abuse Pharmacotherapy Development in the Private Sector. Proceedings of the 60th Annual Meeting, The College of Problems on Drug Dependence (1999), U.S. Department of Health & Human Services, Bethesda, MD 20
16. H.S. Lotsof, U.S. Patent 4,499,096
17. Chem. Abstr. 102 (1985) 160426w
18. H.S. Lotsof, U.S. Patent 4,587,243
19. Chem. Abstr. 106 (1986) 12967r
20. H.S. Lotsof, U.S. Patent 4,857,523
21. Chem. Abstr. 112 (1989) 32041m
22. H.S. Lotsof, U.S. Patent 5,026,697
23. Chem. Abstr. 116 (1991) 17031x
24. H.S. Lotsof, U.S. Patent 5,152,994
25. Chem. Abstr. 116 (1992) 100980b
26. Dzoljic E.D., Kaplan C.D., and Dzoljic M.R. Arch. Int. Pharmacodyn. Ther. 294 (1988) 64
27. Glick S.D., Rossman K., Steindorf S., Maisonneuve I.M., and Carlson J.N. Eur. J. Pharmacol. 195 (1991) 341
28. Maisonneuve I.M., Keller R.W.J., and Glick S.D. Eur. J. Pharmacol. 199 (1991) 35
29. Rand R. The Truth Seeker 117 (1990) 27
30. Sisko B. Multidiscip. Assoc. Psychedel. Stud. Newsl. 4 (1993) 15
31. Kaplan C.D., Ketzer E., DeJong J., and DeVires M. Social Neurosci. Bull. 6 (1993) 6
32. Sheppard S.G. J. Subst. Abuse Treat. 11 (1994) 379
33. Court of Appeal at the Hague. Order of the Court (1999) Cause List Number: 97179K09
34. van den Brink W., Hendriks V.M., Blanken P., and van Ree J.M. Ned Tjdschr Geneeskd 144 (2000) 108
35. Luciano D. Am. J. Addict. 7 (1998) 89
36. Luciano D., Della Sera E.A., and Jethmal E.G. Multidiscip. Assoc. Psychedel. Stud. Bull. 9 (2000) 27
37. Healing Visions. Healing Visions-Narcotic Addiction Recovery Using Ibogaine (2000). http://ibogaine.net
38. E. Taub, Personal communication, August 2000
39. Kent J. An Interview with Eric Taub (1999). http://www.xs4all.nl/~knehav/taubinterview.html
40. Goutarel R., Gollnhofer O., and Sillans R. Psychedel. Mono. Essays 6 (1993) 70
41. Judd B. Ibogaine, Psychotherapy, and the Treatment of Substance-Related Disorders. The Eighth International Conference on Drug Related Harm. Washington, DC (November 19, 1994)
42. Grof S. LSD Psychotherapy (1980), Hunter House, Pomona, CA
43. Yensen R. J. Psychoact. Drugs 17 (1985) 267
44. Strassman R.J. J. Nerv. Ment. Dis. 183 (1995) 127
45. Grund J.P. Intl. J. Drug Policy 6 (1995) 65
46. Bastiaans J. Rev. Med. Chir. Soc. Med. Nat. Iasi 59 (1974) 573
47. Bastiaans J. Mental Liberation Facilitated by the Use of Hallucinogenic Drugs: Psychedelic Reflections (1983), Human Sciences Press, New York
48. Snelders S. Multidiscip. Assoc. Psychedel. Stud. Bull. 8 (1998) 18
49. Ka-tzetnik 135633. Shivitti (1989), Harper and Row, New York
50. M. Resinovic, Personal communication, March 27, 2000.
51. Iboga U. Ustanova Iboga (2000). http://www.ustanova-iboga.si
52. Kastelic A. Self-Help Use of Ibogaine in Slovenia. Presented at the First International Conference on Ibogaine. New York (November 5, 1999)
53. C. Waltenburg, Personal communication, March 2, 2000.
54. Indra. Indra Shamanic Herbarium (2000). http://www.indra.dk
55. egroups. Ibogaine Mailing List (2000). http://www.egroups.com/group/ibogaine
56. Danish Drug User's Union. Drug User's Union (1999). http://www.brugerforeningen.dk
57. R.T. Lionheart, Personal communication, September 2000.
58. Witter S. The Times Magazine (London) (July 11, 1998)
59. Cures-not-Wars. Cures-not-Wars (2000). http://www.cures-not-wars.org
60. Sanders C. Schmoo Connection: Ibogaine (1998). http://www.schmoo.co.uk/iboa.htm
61. Sandberg N. Ibogaine.co.uk (1998). http://www.ibogaine.co.uk
62. C. Sanders, Personal communication, August/November 2000.
63. Sandberg N. Ibogaine Supply and Treatment Options (2000). http://www.ibogaine.co.uk/options.htm
64. B. Mariano, Personal communication, October 2000.
65. Lieberman D. African Ethnobotanical Homepage (1998). http://ibogaine.lycaeum.org
66. Lieberman D. Technology Transfer and Tabernanthe Iboga Treatments: The Application of Relevant Traditional Bwiti Techniques to a Western Medical Setting. Presented at the First International Conference on Ibogaine (November 6, 1999)
67. Brendtro M.J. Adv. Prac. Nurs. Quart. 4 (1998) 54
68. Anglin M.K. Soc. Sci. Med. 44 (1997) 1403
69. McKean A. Why We Get Arrested (2000). http://www.actupny.org/documents/whywe%20get.html
70. Stansill P.S., and Mairowitz D.Z. BAMN-Outlaw Manifestos and Ephemera 1965-1970 (1999), Autonomedia, New York
71. de Jong R. In: Apter D.E., and Joll J. (Eds). Anarchism Today (1971), Macmillian, London 164
72. van de Wijngaart G.F. Am. J. Drug Alcohol Abuse 14 (1988) 125
73. Friedman S.R., de Jong W.M., and Des Jarlais D.C. In: Platt J.J. (Ed). The Effectiveness of Drug Abuse Treatment: Dutch and American Perspectives (1990) 315
74. Kaplan C.D., Morival M., Sterk C., and Division of Epidemiology and Statistical Analysis. Needle-Exchange IV Drug Users and Street IV Drug Users: A Comparison of Background Characteristics, Needle, Sex Practices and AIDS Attitudes. Community Epidemiology Work Group Proceedings: Selected Issues: Acquired Immunodeficiency (AIDS) (1986), Drug Abuse and Crime, Ethnographic Research, Rockville, MD IV-16-IV-25 National Institute on Drug Abuse
75. Grund J.P., Kaplan C.D., and Adriaans N.F.P. Am. J. Public Health 81 (1991) 1602
76. Grund J.P., Blanken P., Adriaans N.F.P., Kaplan C.D., Barendregt C., and Meeusen M. J. Psychoact. Drugs 24 (1992) 41
77. H.S. Lotsof, Personal communication, July 2000.
78. Blakeslee S. New York Times (1993) C-11 October 27
79. Park P. Miami New Times 12 (1997) 16
80. Koerner B.I. US News & World Report 127 (1999) 82
81. Bors J. The Baltimore Sun (1993) 1 August 9